Baxter Theranova: More Middle Molecules, Less Albumin Loss
Baxter’s new dialyzer mimics the function of natural kidneys more closely, removing more middle molecules with no replacement fluid needed—and minimal loss of vital albumin. The new expanded hemodialysis (HDx) therapy has been tested in the UK, where it reduced beta-2 microglobulin levels by more than 11%
Read the full article » | Posted 12/14/2017
Related Articles
- Downsizing Dialysis with New Membrane Materials Posted 12/14/2018
- How Your Stomach May One Day Help Your Kidneys Posted 12/14/2018
- $2.625M in Prize Money to Improve Treatment Options for Kidney Failure Posted 10/12/2018
- Dean Kamen Has $80M from the DOD and an ARMI to Grow Human Organs Posted 10/12/2018
- Quanta Nears UK Launch Posted 09/10/2018